You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 130 No. 1, January 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (28)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Oncology
 •Head & Neck Cancer
 •Neoplasms of Head & Neck
 •Pathology of Head & Neck
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Intraoperative Molecular Margin Analysis in Head and Neck Cancer

David Goldenberg, MD; Susan Harden, MD; Brett G. Masayesva, MD; Patrick Ha, MD; Nicole Benoit, BSc; William H. Westra, MD; Wayne M. Koch, MD; David Sidransky, MD; Joseph A. Califano, MD

Arch Otolaryngol Head Neck Surg. 2004;130:39-44.

Background  Tumor-specific molecular alterations in surgical margins have been shown to predict risk of local recurrence. However, assays used for these analyses are time-consuming and therefore cannot be used in the intraoperative setting.

Objective  To detect and quantify tumor-specific methylated promoter sequences in surgical margins in a time frame suitable for intraoperative use.

Design  A novel quantitative methylation-specific polymerase chain reaction (QMSP) protocol.

Methods  A total of 13 patients with head and neck squamous cell carcinoma (HNSCC) were initially characterized for molecular alterations in their tumor at the time of biopsy. Six primary tumors were found to harbor promoter hypermethylation for p16 and O6–methylguanine-DNA-methyltransferase (MGMT) genes. Rapid QMSP was then used to identify promoter hypermethylation of these genes in the surgical margins. Results were compared with standard intraoperative histologic frozen section analysis and with conventional QMSP.

Results  Using our rapid QMSP assay, we found that 3 patients had methylation-positive margins. Tumor margins from 2 patients were methylated for p16 alone, and margins from 1 patient were methylated for p16 and MGMT simultaneously. Molecular margin analysis was completed in less than 5 hours, a time frame appropriate for selected major HNSCC resections that require combined primary tumor resection, cervical lymphadenectomy, and complex reconstruction. This technique was comparable in sensitivity to conventional QMSP.

Conclusion  Rapid molecular margin analysis using QMSP is feasible and may be performed intraoperatively in selected patients with HNSCC that requires extensive resection.


From the Departments of Otolaryngology–Head and Neck Surgery (Drs Goldenberg, Harden, Masayesva, Ha, Koch, Sidransky, and Califano and Ms Benoit) and Pathology(Dr Westra), The Johns Hopkins University School of Medicine, Baltimore, Md. The authors have no relevant financial interest in this article.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Methylation Array Analysis of Preoperative and Postoperative Saliva DNA in Oral Cancer Patients
Viet and Schmidt
Cancer Epidemiol. Biomarkers Prev. 2008;17:3603-3611.
ABSTRACT | FULL TEXT  

Frequently Methylated Tumor Suppressor Genes in Head and Neck Squamous Cell Carcinoma
Bennett et al.
Cancer Res. 2008;68:4494-4499.
ABSTRACT | FULL TEXT  

Fluorescence Visualization in Oral Neoplasia: Shedding Light on an Old Problem.
Westra and Sidransky
Clin. Cancer Res. 2006;12:6594-6597.
FULL TEXT  

Fluorescence Visualization Detection of Field Alterations in Tumor Margins of Oral Cancer Patients.
Poh et al.
Clin. Cancer Res. 2006;12:6716-6722.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.